Investor News Oliver Maier Head of Investor Relations Fresenius Medical Care Else-Kr ner-Stra e 1 61352 Bad Homburg Germany T +49 6172 609-2601 F +49 6172 609-2301 oliver.maier@fmc-ag.com www.freseniusmedicalcare.com

Fresenius Medical Care provides historical segment data

Bad Homburg, Germany Fresenius Medical Care AG & Co. KGaA ( the company or Fresenius Medical Care ), the world s largest provider of dialysis products and services, has aligned the disclosure of segments in the first quarter 2015.

Hereinafter we provide an update of historical quarterly numbers for 2014, reflecting both, the changes in the disclosure of the segments as well as the additional information provided on Care Coordination. All numbers are on a reported basis and in US$. Changes to the actual currency environment are obviously not reflected.

This Investor News will be published also on the Company s website www.freseniusmedicalcare.com in the section News .

Fresenius Medical Care is the world s largest provider of products and services for individuals with renal diseases of which more than 2.6 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,421 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 289,610 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of additional medical services in the field of care coordination.

For more information about Fresenius Medical Care, visit the company s website at www.freseniusmedicalcare.com.

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA s reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Number prior year according to changes in segment disclosure and additional data on Care Coordination: